Ankeny, IA, United States of America

Kimberly E Glassman

This inventor holds 2 USPTO granted patents. Top assignee: Pioneer Hi-Bred International, Inc.. Active years: 2011-2012.


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2011-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Kimberly E. Glassman

Introduction

Kimberly E. Glassman is a notable inventor based in Ankeny, Iowa. She has made significant contributions to the field of biotechnology, particularly in the area of polynucleotide research. With a total of 2 patents to her name, her work has implications for genetic engineering and plant biology.

Latest Patents

Her latest patents include "Polynucleotides encoding stop codons in multiple reading frames and methods of use." This invention provides compositions that include isolated polynucleotides, expression cassettes, and vectors. These compositions can be utilized in various organisms to stop the translation of mRNA into proteins. Another significant patent is "Methods and compositions for in planta production of inverted repeats." This invention allows for the production of inverted repeats in plants, which can be used to decrease the expression of target polynucleotides.

Career Highlights

Kimberly Glassman is currently employed at Pioneer Hi-Bred International, Inc., where she continues to advance her research in biotechnology. Her work has been instrumental in developing innovative methods that enhance plant genetic engineering.

Collaborations

She has collaborated with notable colleagues such as Karri Klein and Rudolf Jung, contributing to a dynamic research environment that fosters innovation.

Conclusion

Kimberly E. Glassman is a pioneering inventor whose work in biotechnology has the potential to transform agricultural practices and genetic research. Her contributions are vital to the ongoing advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…